Skip to main content

Table 3 Complete Response Rates

From: Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis

  

Luminal A

Luminal B (HER2-negative)

Luminal B (Her2-positive)

HER2-positive

Triple negative

Number of patients with molecular subtype

30

17

18

13

24

Percent of patients with subtype achieving:

 

Standard pathology pCR (%)

3.3

11.7

33.3

46.2

41.7

Chevallier 1 (%)

3.3

23.5

27.8

38.5

33.3

MR 5 (%)

3.3

17.6

56.3

61.5

45.8

  1. Abbreviations: pCR pathologic complete response, MR Modified-RECIST